376 results in Exploration of Targeted Anti-tumor Therapy
Most Viewed
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Perspective
Application of explainable artificial intelligence integrating with electronic health record in oncology
Yuhan Yang, Xici Liu
Published: February 04, 2026 Explor Target Antitumor Ther. 2026;7:1002357
Open Access
Original Article
Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data
Fabrizio Nelli ... Agnese Fabbri
Published: January 20, 2025 Explor Target Antitumor Ther. 2025;6:1002287
This article belongs to the special issue Immune Checkpoint Therapy and Biomarkers in Cancer
Open Access
Original Article
Evaluation of molecular effects associated with apoptosis, tumour progression, angiogenesis and metastasis by a novel combination of drugs with ormeloxifene in triple negative breast cancer cells
Shehna Sharaf ... Lakshmi S
Published: June 11, 2024 Explor Target Antitumor Ther. 2024;5:551–567
This article belongs to the special issue Innovative Strategies to Target Triple-negative Breast Cancer
Open Access
Systematic Review
Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
Veronica Agostinelli ... Rossana Berardi
Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1095–1103
This article belongs to the special issue COVID-19 and Cancer
Open Access
Original Article
A viral circular RNA in Kaposi’s sarcoma-associated herpesvirus modulates viral and host gene expression during latent and lytic replication
Soleil Torres ... Rolf Renne
Published: May 29, 2025 Explor Target Antitumor Ther. 2025;6:1002320
This article belongs to the special issue Potential of Non-Coding RNAs in Cancer Research and Treatment
Open Access
Systematic Review
Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review
Afrooz Mazidimoradi ... Hamid Salehiniya
Published: October 26, 2023 Explor Target Antitumor Ther. 2023;4:1039–1058
This article belongs to the special issue COVID-19 and Cancer
Open Access
Editorial
Exploration of Targeted Anti-tumor Therapy: a contribution to the development of targeted therapies
Nicola Normanno, Graham Packham
Published: February 29, 2020 Explor Target Antitumor Ther. 2020;1:1–2
Open Access
Systematic Review
Diagnostic and prognostic role of NLR in testicular cancer
Shirin Sarejloo ... Brandon Lucke-Wold
Published: September 19, 2024 Explor Target Antitumor Ther. 2024;5:1177–1198
This article belongs to the special issue Emerging Molecular Targets and Therapies of Genitourinary Tumors
Open Access
Case Report
Unexpected “Lazarus response” to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer
Alexey V. Emshanov ... Evgeny N. Imyanitov
Published: December 06, 2023 Explor Target Antitumor Ther. 2023;4:1157–1164
Open Access
Review
Inflammatory signatures across four photon radiotherapy and proton radiotherapy: mechanisms, mitigation, and quality of life impact
Yuting Sheng ... Yujiang Fang
Published: August 28, 2025 Explor Target Antitumor Ther. 2025;6:1002334
Open Access
Case Report
Spontaneous regression of a metastatic carcinoma transmitted by a kidney graft
Mikhail V. Kiselevskiy ... Irina Zh. Shubina
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:511–518
Open Access
Original Article
A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic
Zelmira Ballatore ... Rossana Berardi
Published: September 07, 2023 Explor Target Antitumor Ther. 2023;4:793–800
This article belongs to the special issue COVID-19 and Cancer
Open Access
Original Article
Assessment of lipid peroxidation and total antioxidant capacity in patients with breast cancer
Abdullatif Taha Babakr, Mohamed Mahmoud Nour Eldein
Published: January 02, 2025 Explor Target Antitumor Ther. 2025;6:1002284
Open Access
Original Article
Comparison of outcomes of neoadjuvant chemotherapy in BRCA1- versus BRCA2-associated breast and ovarian cancers
Anna Sokolenko ... Evgeny Imyanitov
Published: June 18, 2025 Explor Target Antitumor Ther. 2025;6:1002325
Open Access
Original Article
Cadmium nanocluster as a safe nanocarrier: biodistribution in BALB/c mice and application to carry crocin to breast cancer cell lines
Moslem Jafarisani ... S. Zahra Bathaie
Published: May 28, 2024 Explor Target Antitumor Ther. 2024;5:522–542
Open Access
Original Article
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity
Melissa Bersanelli ... Luca Ampollini
Published: August 31, 2023 Explor Target Antitumor Ther. 2023;4:743–756
Open Access
Original Article
Synergistic anticancer efficacy of optimized curcumin-piperine loaded magnetic nanoparticles for the treatment of colorectal cancer
Ritika Puri, Vimal Arora
Published: October 20, 2025 Explor Target Antitumor Ther. 2025;6:1002340
This article belongs to the special issue Potential Clinical Applications of Inorganic Nanomaterials in Cancer
Open Access
Review
Role of microbiota in the outcome of immune checkpoint inhibition therapy of cancer
Ger T. Rijkers ... Frans J. van Overveld
Published: November 18, 2025 Explor Target Antitumor Ther. 2025;6:1002348
Open Access
Letter to the Editor
Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma
Sara Tahbazzadeh Moghaddam, Mohammad Mahdi Forghanifard
Published: April 24, 2023 Explor Target Antitumor Ther. 2023;4:217–226
Open Access
Review
Glioblastoma pathophysiology: roles of aging driven changes in STAT3 interactions with NF-κB dimer components in the modulation of the mitochondrial melatonergic pathway and night-time inflammation resolution
George Anderson
Published: February 13, 2026 Explor Target Antitumor Ther. 2026;7:1002358
Previous